Complications of medical and surgical care

Y50.2 Methylxanthines, not elsewhere classified Y50.8 Other central nervous system stimulants Y50.9 Central nervous system stimulant, unspecified Y51 Drugs primarily affecting the autonomic nervous system Y51.0 Anticholinesterase agents Y51.1 Other parasympathomime tics [cholinergics] Y51.2 Ganglionic blocking drugs, not elsewhere classified Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified Y51.4 Predominantly alpha- adrenoreceptor agonists, not elsewhere classified Y51.5 Predominantly beta- adrenoreceptor agonists, not elsewhere classified Y51.6 Alpha- adrenoreceptor antagonists, not elsewhere classified Y51.7 Beta- adrenoreceptor antagonists, not elsewhere classified Y51.8 Centrally acting and adrenergic- neuron-blocking agents, not elsewhere classified Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system Y52 Agents primarily affecting the cardiovascular system Y52.0 Cardiac-stimulant glycosides and drugs of similar action Y52.1 Calcium-channel blockers Y52.2 Other antidysrhythmic drugs, not elsewhere classified Y52.3 Coronary vasodilators, not elsewhere classified Y52.4 Angiotensin- converting-enzyme inhibitors Y52.5 Other antihypertensive drugs, not elsewhere classified Y52.6 Antihyperlipidaemi c and antiarteriosclerotic drugs Y52.7 Peripheral vasodilators Y52.8 Antivaricose drugs, including sclerosing agents Y52.9 Other and unspecified agents primarily affecting the cardiovascular system Y53 Agents primarily affecting the gastrointestinal system Y53.0 Histamine H2- receptor antagonists Y53.1 Other antacids and anti-gastric- secretion drugs Y53.2 Stimulant laxatives Y53.3 Saline and osmotic laxatives Y53.4 Other laxatives Y53.5 Digestants Y53.6 Antidiarrhoeal drugs Y53.7 Emetics Y53.8 Other agents primarily affecting the gastrointestinal system Y53.9 Agent primarily affecting the gastrointestinal system, unspecified Y54 Agents primarily affecting water- balance and mineral and uric acid metabolism Y54.0 Mineralocorticoids Y54.1 Mineralocorticoid antagonists [aldosterone antagonists] Y54.2 Carbonic- anhydrase inhibitors Y54.3 Benzothiadiazine derivatives Y54.4 Loop [high-ceiling] diuretics Y54.5 Other diuretics Y54.6 Electrolytic, caloric and water-balance agents Y54.7 Agents affecting calcification Y54.8 Agents affecting uric acid metabolism Y54.9 Mineral salts, not elsewhere classified Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system Y55.0 Oxytocic drugs Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]